Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000487313 | SCV000574420 | uncertain significance | not provided | 2017-03-30 | criteria provided, single submitter | clinical testing | The Y481C variant in the RARS2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The Y481C variant is observed in 1/66734 (0.0015%) alleles from individuals of non-Finnish European background in the ExAC dataset (Lek et al., 2016). The Y481C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved across species, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, we interpret Y481C as a variant of uncertain significance. |
Breakthrough Genomics, |
RCV000487313 | SCV005189154 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001829392 | SCV002079895 | uncertain significance | Pontocerebellar hypoplasia type 6 | 2019-11-11 | no assertion criteria provided | clinical testing |